Status:
COMPLETED
Efficacy Evaluation of Dai Dai Flower on Body Weight
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Gastroenterology
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
To assess the Dai Dai flower extract on body weight control
Eligibility Criteria
Inclusion
- Healthy male or female aged between 20 and 60 years old
- Body mass index (BMI) ≥ 24 (kg/m\^2) or body fat mass ≥ 25%
Exclusion
- Pregnant or breastfeeding woman
- Implementation in weight loss programs, consumption drugs or supplements for weight control before 3 months of this study
- Participate weight control or fat loss human studies before 3 months of this study
- History of cardiovascular disease, liver disease, kidney disease, endocrine disease, or other major organic diseases (according to subjects reporting).
- Person who has received major surgery or bariatric surgery (according to medical history).
- Person who has received constant drug use.
- People with mental illness
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04692792
Start Date
January 4 2021
End Date
June 15 2021
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University
Taichung, Taiwan, 404